Aktie 003017 ZHE JIANG DAYANG BIOTECH GROUP CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Zhe Jiang Dayang Biotech Group Co., Ltd.

Aktien

003017

CNE100004736

003017

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 21.06.2024 		% 5 Tage % 1. Jan.
16,18 CNY 0,00 % Intraday Chart für Zhe Jiang Dayang Biotech Group Co., Ltd. -3,06 % -33,47 %
22.05. Zhe Jiang Dayang Biotech Group Co., Ltd. beschließt Bardividende für das Jahr 2023 CI
26.04. Zhe Jiang Dayang Biotech Group Co., Ltd. schlägt endgültige Bardividende für 2023 vor CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Zhe Jiang Dayang Biotech Group Co., Ltd. Approves Cash Dividend for the Year 2023
Zhejiang Xinzhichun Semiconductor Materials Co., Ltd. announced that it has received CNY 14.7143 million in funding from Zhe Jiang Dayang Biotech Group Co., Ltd.
Zhe Jiang Dayang Biotech Group Co., Ltd. Proposes Final Cash Dividend for 2023
Tranche Update on Zhe Jiang Dayang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.
Zhe Jiang Dayang Biotech Group Co., Ltd. announces an Equity Buyback for CNY 84 million worth of its shares.
Zhe Jiang Dayang Biotech Group Co., Ltd. authorizes a Buyback Plan.
Zhejiang Dayang Biotech Group Co., Ltd. Approves Interim Cash Dividend for the Year 2023, Payable on November 14, 2023
Certain A Shares of Zhejiang Dayang Biology Technology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 27-OCT-2023.
Zhejiang Dayang Biotech Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhejiang Dayang Biotech Group Co., Ltd. Approves Interim Cash Dividend for the Year 2023
Zhejiang Dayang Biotech Group Co., Ltd. Announces the Profit Distribution Proposal for the First Half of 2023
Zhejiang Dayang Biotech Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Fujian Shunyue Technology Co., Ltd. announced that it expects to receive CNY 96.672753 million in funding from Zhe Jiang Dayang Biotech Group Co., Ltd.
Zhejiang Dayang Biology Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 29 June 2023
Dayang Biotech Vice Chairman Dies of Illness
Zhejiang Dayang Biology Technology Co.,Ltd. Approves Cash Dividend for the Year 2022
Zhejiang Dayang Biology Technology Co.,Ltd. Proposes Cash Profit Distribution for 2022
Zhejiang Dayang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Zhejiang Dayang Biotech Sells Idle Properties
Zhejiang Dayang Biology Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 003017 Aktie
  4. Nachrichten Zhe Jiang Dayang Biotech Group Co., Ltd.
  5. Andere Sprachen